New Times,
New Thinking.

  1. Business
  2. Economics
26 June 2012

Osborne’s failure on the deficit becomes clearer

Borrowing is £2.7bn higher than a year ago.

By George Eaton

According to David Cameron, deficit reduction is the “guiding task” of the coalition, so it’s unfortunate that he’s not very good at it. The latest figures from the ONS show that his government borrowed £17.9bn in May, £2.7bn more than a year ago. Worse, the total deficit for 2011-12 has been revised up by £3.2bn to £127.6bn, and the national debt is now £1.0134 trillion (65% of GDP), a stat that will terrify the fiscal conservatives in Osborne’s party.

In his “emergency Budget” in 2010, Osborne claimed that “unless we deal with our debts there will be no growth”. But as all Keynesians know, the reverse is true. Unless you stimulate growth, you can’t deal with your debts. With the economy back in recession, income tax receipts are down 7 per cent on May 2011.

The Chancellor once hoped to go to the election boasting that he had “balanced the books” and cleaned up “the mess” left by Labour. Now, with 2015 borrowing likely to exceed even the OBR’s recent forecast of £75bn (4.3 per cent), the question voters will ask is “what was all the pain for?”

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines